NXL-001 for stroke recovery: a safety study
Part of Brain & nervous system, Heart & circulation clinical trials.
This trial tests a new treatment called NXL-001 for people who have had a stroke affecting movement. The goal is to see if it is safe and if it can help improve motor function. It is for those who still have moderate to severe weakness 2-4 months after their stroke.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are between 40 and 75 years old.
- You had a stroke 2-4 months ago that affected movement in one arm or leg.
- Your stroke caused moderate to severe weakness (NIHSS score 6-20).
- You have had standard rehab but still have trouble moving.
- You are willing to come for follow-up visits and do rehabilitation training.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests a new treatment called NouvSoma001 for people who have had an ischemic stroke within the last week. It aims to see if the treatment is safe and helps improve muscle strength and overall recovery.
This trial tests a new medicine called SP-8203 added to standard clot-busting treatment for people having a moderate to severe stroke. The goal is to see if it helps improve recovery and is safe.
This trial tests whether carefully targeted, noninvasive electrical stimulation of the brain can improve arm and overall recovery after an ischemic stroke. It may help by supporting brain relearning during the first weeks after stroke.
This trial tests whether stem cell-derived extracellular vesicles can help people recover after a moderate to severe stroke. You may join if you had a stroke in the last 5 days and still have arm or leg weakness, even after standard treatments like clot-busting drugs or clot removal.
This study tests a new medicine called NTS-521 given through an IV. It is for people who recently had a stroke that caused weakness on one side of the body. The trial aims to see if the medicine can help improve recovery after a stroke.
This trial tests whether a non-invasive brain stimulation device used alongside stroke rehabilitation can improve recovery after stroke. It may help people regain function during a phase when stroke effects have stabilized but recovery is still possible.
Hear when a new Ischemic Stroke trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.